Key result
EVITE mobile app enters RCT testing to evaluate lifestyle and treatment adherence after coronary events.
Why the study?
Coronary event survivors face high risks of readmission, relapse, and mortality due to sub-optimal control of cardiovascular risk factors, highlighting the need to improve secondary prevention strategies for lifestyle and treatment adherence.
Does an online mHealth application improve lifestyle and treatment adherence in patients with coronary heart disease after percutaneous coronary intervention?
RCT (n=240)
Single-blind
Computer-generated random numbers (1:1)
No
Does an online mHealth application improve lifestyle and treatment adherence in patients with coronary heart disease after percutaneous coronary intervention?
Answers are grounded in this paper and cite their sources.
This protocol describes a planned randomized controlled trial to evaluate the efficacy of an interactive web application on lifestyle and treatment adherence in patients after a coronary event.
Coronary heart disease is one of the main causes of morbimortality around the world. Patients that survive a coronary event suffer a high risk of readmission, relapse and mortality, attributed to the sub-optimal control of cardiovascular risk factors (CVRF), which highlights the need to improve secondary prevention strategies aimed at improving their lifestyle and adherence to treatment. Through a randomized controlled clinical trial, this study aims to evaluate the effect of an intervention involving an online health application supported by a mobile telephone or tablet (mHealth) on lifestyle (diet, physical activity, and tobacco consumption) and treatment adherence among people with coronary heart disease after percutaneous coronary intervention. The sample will comprise 240 subjects (120 in each arm: intervention and usual care). They are assessed immediately and nine months after their hospital discharge about sociodemographic, clinical, CVRF, lifestyle, and treatment adherence characteristics. The educative intervention, involving a follow-up and self-monitoring, will be performed using an online mHealth tool consisting of an application for mobile phones and tablets. The quantitative primary outcomes from the two groups will be compared using an analysis of covariance (ANCOVA) adjusted for age and gender. A multivariate analysis will be performed to examine the association of the intervention with lifestyle habits, the control of CVRFs, and outcomes after discharge in terms of the use of health services, emergency visits, cardiovascular events and readmissions.
No takes yet. Share an insight, caveat, or question.
Bernal-Jiménez et al. (2021) conducted an RCT in Coronary heart disease after percutaneous coronary intervention (n=240). EVITE mobile health application vs. Usual care was evaluated on Changes in behavior relating to healthy diet, physical activity, smoking cessation, treatment adherence, knowledge acquired, usability and satisfaction. The EVITE mobile health application intervention will be evaluated in a randomized controlled trial of 240 patients to determine its effect on lifestyle and treatment adherence after a coronary event.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: